Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Nervous System Diseases 1Epilepsy 1Brain Neoplasms 1

Interventions

Specimen Handling 13Magnetic Resonance Spectroscopy 13lutetium Lu 177 dotatate 10cabozantinib 6Nivolumab 5X-Rays 4Ipilimumab 4Cisplatin 4pembrolizumab 3olaparib 3fludarabine 3Phantoms, Imaging 3Everolimus 3Etoposide 3Cyclophosphamide 3Carboplatin 3CTLA-4 Antigen 3gallium Ga 68 dotatate 2fluorodopa F 18 2aldesleukin 2Temozolomide 2Lutetium-177 2Lutetium 2Irinotecan 2Fluorodeoxyglucose F18 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 2trametinib 1tipifarnib 1sodium thiosulfate 1selpercatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clinical Laboratory Techniques × Endocrine × 30 days × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡